Cva Family Office, LLC Pfizer Inc Transaction History

Cva Family Office, LLC

$606 Million
Q3 2024

A detailed history of Cva Family Office, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cva Family Office, LLC holds 12,015 shares of PFE stock, worth $309,626. This represents 0.06% of its overall portfolio holdings.

Number of Shares

12,015

Previous 11,998 0.14%

Holding current value

$309,626

Previous $335,000 3.58%

% of portfolio

0.06%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$27.7 - $31.39 $470 - $533	17 Added 0.14%	12,015 $347,000
Q2 2024 Jul 09, 2024	BUY	$25.26 - $29.6 $165,250 - $193,643	6,542 Added 119.9%	11,998 $335,000
Q1 2024 Apr 10, 2024	SELL	$25.89 - $29.73 $139,521 - $160,214	-5,389 Reduced 49.69%	5,456 $151,000
Q4 2023 Jan 16, 2024	SELL	$26.13 - $33.94 $95,870 - $124,525	-3,669 Reduced 25.28%	10,845 $312,000
Q3 2023 Oct 11, 2023	SELL	$32.09 - $37.51 $86,386 - $100,976	-2,692 Reduced 15.65%	14,514 $481,000
Q2 2023 Jul 10, 2023	BUY	$36.12 - $41.79 $92,647 - $107,191	2,565 Added 17.52%	17,206 $631,000
Q1 2023 Apr 26, 2023	SELL	$39.39 - $51.28 $133,847 - $174,249	-3,398 Reduced 18.84%	14,641 $597,000
Q4 2022 Feb 21, 2023	BUY	$41.75 - $54.5 $53,899 - $70,359	1,291 Added 7.71%	18,039 $924,000
Q3 2022 Nov 22, 2022	BUY	$43.76 - $53.42 $28,750 - $35,096	657 Added 4.08%	16,748 $733,000
Q2 2022 Jul 11, 2022	BUY	$46.53 - $55.17 $62,955 - $74,645	1,353 Added 9.18%	16,091 $844,000
Q1 2022 Apr 22, 2022	SELL	$45.75 - $56.69 $20,679 - $25,623	-452 Reduced 2.98%	14,738 $763,000
Q4 2021 Jan 25, 2022	BUY	$41.32 - $61.25 $251,266 - $372,461	6,081 Added 66.76%	15,190 $897,000
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $209,516 - $269,141	-5,338 Reduced 36.95%	9,109 $334,000
Q2 2021 Jul 13, 2021	BUY	$35.91 - $40.68 $39,070 - $44,259	1,088 Added 8.14%	14,447 $566,000
Q1 2021 Apr 14, 2021	BUY	$33.49 - $37.77 $120,530 - $135,934	3,599 Added 36.88%	13,359 $484,000
Q4 2020 Jan 15, 2021	BUY	$33.47 - $42.56 $21,788 - $27,706	651 Added 7.15%	9,760 $359,000
Q3 2020 Oct 27, 2020	BUY	$31.75 - $37.25 $37,369 - $43,843	1,177 Added 14.84%	9,109 $334,000
Q2 2020 Jul 31, 2020	BUY	$30.12 - $36.54 $41,113 - $49,877	1,365 Added 20.79%	7,932 $259,000
Q1 2020 May 28, 2020	BUY	$27.03 - $38.62 $13,677 - $19,541	506 Added 8.35%	6,567 $214,000
Q4 2019 Feb 18, 2020	BUY	$32.92 - $37.36 $199,528 - $226,438	6,061 New	6,061 $237,000

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.

Account

Cva Family Office, LLC Pfizer Inc Transaction History